Barely Significant
← all excerpts

Proteomic Analyses Identify Therapeutic Targets in Hepatocellular Carcinoma.

Front Oncol · 2022 · PMC9006883 · PMID 35433463

1
hedged sentence
closest p
boldest claim

The sentences

In addition, we observed a trend of improved recurrence-free survival in the HCC-Gao patients that did not overexpress FGFR4 protein compared to those overexpressing FGFR4 (p = 0.087; FGFR4-not-overexpressed median survival 23.2 months; FGFR4-overexpressed median survival 9.5 months) ( Figure S8 ), although the association did not reach statistical significance and require validation in future larger-scale cohorts.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.